BMJ  2008;336:1248-1249 (31 May), doi:10.1136/bmj.39580.424352.AD

Practice

Commentary: Controversies in NICE guidance on lipid modification for the prevention of cardiovascular disease

Francesco P Cappuccio, Cephalon chair of cardiovascular medicine and epidemiology1

1 Clinical Sciences Research Institute, University of Warwick Medical School, Coventry CV2 2DX

f.p.cappuccio@warwick.ac.uk

doi: 10.1136/bmj.39554.624086.AD

The first 150 words of the full text of this article appear below.

The new guidelines from the National Institute for Health and Clinical Excellence (NICE) on lipid modification for the prevention of cardiovascular disease will guide the way we assess cardiovascular risk and treat lipids, both in primary and in secondary care. What are the new aspects, and what is it that might spark controversy in this new publication?

Risk assessment

To identify those requiring primary prevention of cardiovascular disease, the guideline reaffirms the threshold of a 10 year cardiovascular disease risk >20% in people aged over 40 years. Its recommendation of a systematic, rather than opportunistic, risk assessment is welcome, particularly in primary care. The new guidelines wisely reaffirm the 1991 Framingham risk score as the score of choice for guiding primary prevention.

However, they also retain subjective, non evidence-based adjustments. They advise increasing the risk estimate by 1.5-2.0 in the presence of premature family history and by 1.4 in South Asian men, . . . [Full text of this article]

Lifestyle advice


Statins and targeting cholesterol levels


Conclusion



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance
Angela Cooper, Norma O’Flynn on behalf of the Guideline Development Group
BMJ 2008 336: 1246-1248. [Extract] [Full Text] [PDF]

Salt and cardiovascular disease
Francesco P Cappuccio
BMJ 2007 334: 859-860. [Extract] [Full Text] [PDF]

Randomised controlled factorial trial of dietary advice for patients with a single high blood pressure reading in primary care
Paul Little, Jo Kelly, Jane Barnett, Martina Dorward, Barrie Margetts, and Daniel Warm
BMJ 2004 328: 1054. [Abstract] [Full Text] [PDF]

Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study
Francesco P Cappuccio, Pippa Oakeshott, Pasquale Strazzullo, and Sally M Kerry
BMJ 2002 325: 1271. [Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

NICE lipid target levels – only for some
Martin Duerden
bmj.com, 9 Jun 2008 [Full text]
BNF printed risk charts - clarification required
Jim C P Newmark
bmj.com, 16 Jun 2008 [Full text]



Student BMJ

Intimate examinations

Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.

www.student.bmj.com

Listen to the latest BMJ Interview